戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ude stored food mites, house dust mites, and scabies).
2 ctious etiologies such as tinea corporis and scabies.
3 ectin mass drug administration (MDA) against scabies.
4 aria might have significant benefits against scabies.
5 and treat approach, for community control of scabies.
6 ttings, where they are often associated with scabies.
7 ect on the severe bacterial complications of scabies.
8 69.41) had the greatest burden of DALYs from scabies.
9 ated induction of thaxtomin production in S. scabies.
10 erpes simplex virus infection, syphilis, and scabies.
11 ybridization profiles was greatest within S. scabies.
12  order to induce the virulent behavior of S. scabies?
13 s, 0.15% for fungal skin diseases, 0.07% for scabies, 0.06% for malignant skin melanoma, 0.05% for py
14 jacent to the 3' end of nec1 in Streptomyces scabies 84.34 identified a new insertion sequence (IS) e
15                         Sequencing of the S. scabies 87-22 genome revealed the presence of a gene wit
16                The actinomycete Streptomyces scabies 87-22 is the causal agent of common scab, an eco
17                        The tomA gene from S. scabies 87-22 was cotranscribed with a putative family 1
18  disease for tomato seedlings affected by S. scabies 87-22 wild-type and DeltatomA1 strains were indi
19 ng of the potato scab pathogen, Streptomyces scabies 87-22, revealed a hopanoid biosynthetic gene clu
20 eliminated in the txtR deletion mutant of S. scabies 87.22.
21 s was reduced compared with the wild-type S. scabies 87.22.
22                                      MDA for scabies also led to a reduction in impetigo prevalence w
23 their skin examined, of whom 261 (18.7%) had scabies and 347 (24.8%) had impetigo.
24 9 were deemed suitable for meta-analysis for scabies and 4 for impetigo.
25 re similar to the esterase from Streptomyces scabies and a brain acetylhydrolase.
26 gent responsible for the pathogenicity of S. scabies and cello-oligosaccharides are environmental tri
27 s drug coadministration on the prevalence of scabies and impetigo 3 years after the intervention.
28 mary analysis, we compared the prevalence of scabies and impetigo at 36 months to the prevalence at b
29         We conducted a prevalence survey for scabies and impetigo in 10 villages in Choiseul Province
30             We report here the prevalence of scabies and impetigo in residents of the ten baseline vi
31 d as a promising strategy for the control of scabies and impetigo in settings where the diseases are
32                                  We measured scabies and impetigo prevalence at baseline and 12 month
33  with ivermectin led to similar decreases in scabies and impetigo prevalence compared to ivermectin a
34  The main outcome assessed was the change in scabies and impetigo prevalence following MDA.
35                                 At baseline, scabies and impetigo prevalences were 11.8% and 10.1% in
36 f mass drug administration of ivermectin for scabies and impetigo, with coadministration of azithromy
37 ghly effective in reducing the prevalence of scabies and impetigo.
38  several studies to reduce the prevalence of scabies and impetigo.
39 to assess the efficacy of MDA for scabies on scabies and impetigo.
40 -analysis of reports on the impact of MDA on scabies and impetigo.
41 ermectin, was efficacious for the control of scabies and impetigo.
42  outcome was the change in the prevalence of scabies and of impetigo from baseline to 12 months.
43 agonism of the potato pathogens Streptomyces scabies and Phytophthora infestans.
44 iogenesis in the plant pathogen Streptomyces scabies and report that lgt and lsp mutants are defectiv
45 ubstantially decrease the prevalence of both scabies and secondary impetigo; however, their effect at
46 linked in Streptomyces strains, including S. scabies and Streptomyces acidiscabies strains, that are
47      Streptomyces acidiscabies, Streptomyces scabies and Streptomyces turgidiscabies possess a conser
48                                              Scabies and syphilis received the lowest relative fundin
49  include scabicides for patients with common scabies and their close contacts.
50 h topical permethrin 5% for individuals with scabies and their household contacts (SAT).
51 s no vaccine or preventive treatment against scabies and, for the past 30 years, only few broad-spect
52 ministration (MDA) reduces the prevalence of scabies and, to a lesser extent, impetigo.
53 in problems were pruritus, eczema, impetigo, scabies, and molluscum contagiosum.
54 ontrol strategies on community prevalence of scabies at 12 months.
55 gest that >200 million people worldwide have scabies at any one time, with an annual prevalence of 45
56 stantial advantages for implementing MDA for scabies at large scale.
57 oned a 9.4-kb DNA fragment from Streptomyces scabies ATCC 41973 that allows the nonpathogen Streptomy
58                                              Scabies, bedbug, and body lice infestations are caused b
59                                              Scabies, bedbug, and body lice infestations are common.
60                                              Scabies, bedbug, and body lice infestations should be tr
61 e more common in elderly patients, including scabies, bullous pemphigoid, transient acantholytic derm
62 des broad and frequently updated measures of scabies burden in terms of skin effects.
63  The five individual countries with greatest scabies burden were Indonesia (age-standardised DALYs 15
64                                              Scabies can be successfully controlled using mass drug a
65 acterial skin diseases, urticaria, pruritus, scabies, cellulitis, and alopecia areata were underrepre
66 ted Rhodococcus species infection, Norwegian scabies, chronic mucocutaneous candidiasis, hypothyroidi
67 uster-randomised trial done in a malaria and scabies co-endemic community in Mozambique.
68 ntervention as a central component of global scabies control efforts.
69 cted a trial of mass drug administration for scabies control in Fiji.
70 ried settings are warranted to inform global scabies control strategies.
71                                              Scabies control will require a multifaceted approach, ai
72  to one of three different interventions for scabies control: standard care involving the administrat
73 rom baseline to 12 months, the prevalence of scabies declined significantly in all groups, with the g
74                                At 12 months, scabies decreased substantially in all groups: IVM-2: 1.
75                Functional analysis of the S. scabies Delta hop615-1 and Delta hop615-7 mutant strains
76       There was no difference in the risk of scabies, dermatophytosis and varicella.
77 itations of the study included the method of scabies diagnosis by nonexperts, a lower baseline preval
78                                              Scabies ED patients that were male, older, insured by Me
79               The average cost of care for a scabies ED visit was $750.91 (+/-17.41).
80 ly representative estimates of the burden of scabies ED visits on the American healthcare system.
81           The average annual expenditure for scabies ED visits was $67 125 780.36.
82          Outcomes included adjusted odds for scabies ED visits, adjusted odds for inpatient admission
83 regional variation in cost and prevalence of scabies ED visits.
84                                We identified scabies epidemiological data sources from an extensive l
85 alopecia areata, decubitus ulcer, urticaria, scabies, fungal skin diseases, impetigo, abscess, and ot
86                           Analysis of the S. scabies genome sequence indicates that it is likely to s
87                      Transcription of the S. scabies HBGC was upregulated during aerial growth, which
88 ration strategies include programs targeting scabies, impetigo, yaws, and diseases causing lymphoedem
89 ions to decrease the incidence and burden of scabies in American EDs.
90 d studies have documented high prevalence of scabies in overcrowded settings, particularly among chil
91 adjusted odds for inpatient admission due to scabies in the ED scabies population, predictors for cos
92 vermectin mass drug administration (MDA) for scabies in the Solomon Islands.
93 n of emergency department (ED) visits due to scabies in the United States.
94  either be idiopathic or may be a sequela of scabies in young infants.
95                                              Scabies infection is highly contagious and leads to cons
96 y specialized metabolites associated with S. scabies inhibition, which was supported by in planta bio
97                                              Scabies is a neglected tropical disease hyperendemic to
98                                              Scabies is a neglected tropical disease of the skin that
99                                              Scabies is a parasitic disease of the skin that dispropo
100                                              Scabies is a public health problem in many countries, wi
101  advances from the past 5 years suggest that scabies is amenable to population-level control, particu
102                                 Streptomyces scabies is an economically important plant pathogen well
103                                              Scabies is an underrecognized cause of illness in many d
104                                              Scabies is caused by mites (Sarcoptes scabiei) that burr
105                                       Common scabies is characterized by excoriated pruritic papules,
106                INTERPRETATION: The burden of scabies is greater in tropical regions, especially in ch
107                                      MDA for scabies is highly effective in reducing the prevalence o
108 e achieved when mass drug administration for scabies is integrated with mass drug administration of a
109                         Summary Streptomyces scabies is one of a group of organisms that causes the e
110                                              Scabies is one of the most common and highest-burden ski
111                                 Streptomyces scabies is the best studied of those streptomycetes that
112                                 Streptomyces scabies is the dominant pathogenic species worldwide, bu
113 proteins are lost from the membrane in an S. scabies lgt mutant but restored by expression of Strepto
114 stulosis of infancy, incontinentia pigmenti, scabies, neonatal and congenital candidiasis, syphilis,
115  approximately 622 million incident cases of scabies occurred globally.
116   We aimed to assess the efficacy of MDA for scabies on scabies and impetigo.
117  produced by fully sporulated cultures of S. scabies on solid ISP4 (International Streptomyces Projec
118 w number of events for some outcomes such as scabies or varicella, which may have led to limited stat
119  do not kill all developmental stages of the scabies parasite.
120 inpatient admission due to scabies in the ED scabies population, predictors for cost of care, and sea
121                       The risk difference in scabies prevalence at 12 months between the IVM-1 and IV
122                     The primary endpoint was scabies prevalence at 3 months.
123                     Secondary endpoints were scabies prevalence in directly exposed participants (tho
124                                              Scabies prevalence in the ivermectin group was lower aft
125 l relative reduction of the impact of MDA on scabies prevalence was 79%.
126                                 At baseline, scabies prevalence was similar in all groups: IVM-2: 11.
127 m 2013 to 2015, of which 356 267 were due to scabies (prevalence = 85.7 per 100 000 ED visits).
128                                 Syphilis and scabies received the least relative investment (both $9
129 d their skin examined, of whom 29 (2.3%) had scabies (relative reduction 88%, 95% CI 76.5-99.3) and 8
130 ed on a conserved pathogenicity island in S. scabies, S. turgidiscabies and S. acidiscabies.
131  plant pathogen 87.22 strain of Streptomyces scabies Scabin shares nearly 40% sequence identity with
132 629 is present in multiple copies in some S. scabies strains and is present in all S. acidiscabies an
133                                      In this scabies substudy, 39 clusters were randomly selected fro
134 olled from 39 clusters (13 per group) in the scabies substudy.
135                       Inactivation of the S. scabies Tat pathway resulted in pleiotropic phenotypes i
136 ermectin is an endectocide effective against scabies that is under evaluation as a malaria vector con
137 st that nec1 may have been mobilized into S. scabies through a transposition event mediated by ORFtnp
138  to cellotriose as possible adaptation of S. scabies to colonize expanding plant tissue.
139    In recognition of these issues, WHO added scabies to the list of neglected tropical diseases in 20
140 ring disfigurement, itch, and pain caused by scabies, to produce years lived with disability (YLDs).
141 otocols and prioritisation efforts and focus scabies treatment and control measures.
142 ion of diethylcarbamazine and albendazole to scabies treatment.
143 -nec1-IS1629 locus from IS1629-containing S. scabies (type II) to S. acidiscabies and S. turgidiscabi
144  provide an estimate of the global burden of scabies using data from the Global Burden of Disease (GB
145 provide population-level estimates regarding scabies visits to American EDs.
146              At 36 months, the prevalence of scabies was 4.7% (95% confidence interval [CI], 3.6-6.1)
147  NOS-dependent nitric oxide production by S. scabies was also reduced in the mutant.
148                    The highest prevalence of scabies was among children aged <5 years (12.5%; adjuste
149                           The odds of having scabies was lower in pooled ivermectin clusters than in
150                                              Scabies was responsible for 0.21% of DALYs from all cond
151                 Patients visiting the ED for scabies were most likely to be male children from lower
152  diagnostic tool for the timely detection of scabies, which could prevent the cycle of exacerbation a
153 The recently available genome sequence of S. scabies will accelerate research on host-pathogen intera
154          With an assumed zero mortality from scabies, YLDs were equivalent to disability-adjusted lif

 
Page Top